Literature DB >> 2823807

Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.

D K Das1, R M Engelman, R Clement, H Otani, M R Prasad, P S Rao.   

Abstract

Xanthine oxidase (XO) has been hypothesized to be a potential source of oxygen-derived free radicals during reperfusion of ischemic myocardium based on the fact that allopurinol, a XO-inhibitor, can reduce reperfusion injury. In this communication we report that both allopurinol and oxypurinol, the principle metabolite of allopurinol, prevent the reperfusion injury in isolated pig heart. However, we found that neither pig heart nor pig blood contain any XO activity. Our study showed a direct free radical scavenging action of these XO-inhibitors during ischemia and reperfusion, as judged by the reduction of free radical signals when compared using an Electron Paramagnetic Resonance Spectrometer. Using a Luminometer, we also confirmed that both allopurinol and oxypurinol can scavenge ClO2, HOCl, and significantly inhibit free radical signals generated by activated neutrophils. These XO-inhibitors, however, failed to scavenge O2. and OH. radicals. Our results suggest that these XO-inhibitors salvaged the ischemic-reperfused myocardium by scavenging free radicals, and not by inhibiting XO in the pig heart.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823807     DOI: 10.1016/0006-291x(87)91112-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  Effects of oxyradicals on oxymyoglobin. Deoxygenation, haem removal and iron release.

Authors:  M R Prasad; R M Engelman; R M Jones; D K Das
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

2.  Stimulation of peroxidative reactions by a high dose of allopurinol in the rat myocardium.

Authors:  F Boucher; C Coudray; A Favier; J de Leiris
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

Review 3.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

4.  Evaluation of purine nucleotide loss, lipid peroxidation and ultrastructural alterations in post-hypoxic hepatocytes.

Authors:  T Grune; K Müller; S Zöllner; R Haseloff; I E Blasig; H David; W Siems
Journal:  J Physiol       Date:  1997-01-15       Impact factor: 5.182

5.  Uric acid as radical scavenger and antioxidant in the heart.

Authors:  B F Becker; N Reinholz; T Ozçelik; B Leipert; E Gerlach
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

6.  Lipid peroxidation in experimental spinal cord injury: time-level relationship.

Authors:  S Barut; A Canbolat; T Bilge; Y Aydin; B Cokneşeli; U Kaya
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

Review 7.  Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review.

Authors:  Seyed Sajad Mohseni Salehi Monfared; Hamed Vahidi; Amir Hossein Abdolghaffari; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

8.  A cell-based approach to study changes in the pancreas following nicotine exposure in an animal model of injury.

Authors:  Parimal Chowdhury; Azida Walker
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

9.  Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage.

Authors:  D J Chambers; A Takahashi; S M Humphrey; D M Harvey; D J Hearse
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

10.  Randomised controlled trial of allopurinol prophylaxis in very preterm infants.

Authors:  G A Russell; R W Cooke
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.